APA (7th ed.) Citation

Becciolini A, Raimondo MG, Crotti C, Agape E, Biggioggero M, & Favalli EG. (2017). A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: Focus on interchangeability. Dove Medical Press.

Chicago Style (17th ed.) Citation

Becciolini A, Raimondo MG, Crotti C, Agape E, Biggioggero M, and Favalli EG. A Review of the Literature Analyzing Benefits and Concerns of Infliximab Biosimilar CT-P13 for the Treatment of Rheumatologic Diseases: Focus on Interchangeability. Dove Medical Press, 2017.

MLA (9th ed.) Citation

Becciolini A, et al. A Review of the Literature Analyzing Benefits and Concerns of Infliximab Biosimilar CT-P13 for the Treatment of Rheumatologic Diseases: Focus on Interchangeability. Dove Medical Press, 2017.